ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 787,23
-1,35%
Dow Jones
38 868,04
0,00%
DAX
18 340,42
-0,80%
Brent Oil
81,505
-0,33%
Bitcoin
67 109,31
-3,45%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Aerovate Therapeutics Inc (AVTE)

  7. Aerovate Therapeutics Inc (AVTE) Actualités

AVTE Aerovate Therapeutics Inc

21,86
0,00 (0,00%)
Avant marché
Dernière mise à jour : 13:00:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Aerovate Therapeutics Inc AVTE NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 21,86 13:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
21,86
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
10/6/202423:00EDGAR2Form S-3 - Registration statement under Securities Act of..
07/6/202423:00EDGAR2Form 8-K - Current report
21/5/202422:15GLOBEAerovate Therapeutics Presents Baseline Data from the Phase..
18/5/202401:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202422:59EDGAR2Form 144 - Report of proposed sale of securities
13/5/202422:57EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202422:39EDGAR2Form 8-K - Current report
13/5/202422:30GLOBEAerovate Therapeutics Announces First Quarter Financial..
27/3/202414:20GLOBEAerovate Therapeutics to Present Patient Baseline..
25/3/202421:10GLOBEAerovate Therapeutics Announces Full-Year 2023 Financial..
11/3/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:37EDGAR2Form 144 - Report of proposed sale of securities
06/3/202414:00GLOBEAerovate Therapeutics Board of Directors Appoints Habib..
28/2/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202400:38EDGAR2Form 144 - Report of proposed sale of securities
09/2/202422:28EDGAR2Form SC 13G - Statement of acquisition of beneficial..
25/1/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202422:29EDGAR2Form 144 - Report of proposed sale of securities
08/1/202423:11EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/1/202413:59EDGAR2Form 8-K - Current report
30/12/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202323:50EDGAR2Form 144 - Report of proposed sale of securities
23/12/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202322:24EDGAR2Form 144 - Report of proposed sale of securities
16/12/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202322:10EDGAR2Form 144 - Report of proposed sale of securities
08/12/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202322:13EDGAR2Form 144 - Report of proposed sale of securities
20/11/202322:46EDGAR2Form 8-K - Current report
20/11/202322:45GLOBEAerovate Therapeutics Announces Simultaneous Completion of..
13/11/202314:03EDGAR2Form 8-K - Current report
13/11/202314:00GLOBEAerovate Therapeutics Announces Third Quarter Financial..
03/11/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/9/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202320:05EDGAR2Form 144 - Report of proposed sale of securities
14/8/202314:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202314:10EDGAR2Form 8-K - Current report
14/8/202314:00GLOBEAerovate Therapeutics Announces Second Quarter Financial..
10/8/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202317:53EDGAR2Form 144 - Report of proposed sale of securities
11/7/202323:03EDGAR2Form 8-K - Current report
11/7/202323:00GLOBEAerovate Therapeutics Appoints Habib Dable To Its Board of..
08/7/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/7/202321:35EDGAR2Form 144 - Report of proposed sale of securities

Dernières Valeurs Consultées

NASDAQ
AVTE
Aerovate Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés